Events communication
OVERVIEW
EFPIA-E4ETHICS.EU RANKINGS
Date Range
Date Range
Date Range
LINKS TO WEB SITE
ПРЕДВАРИТЕЛНО ОЦЕНЯВАНЕ НА СЪБИТИЯТА СПОРЕД ЕТИЧНИЯ КОДЕКС НА НАУЧНОИЗСЛЕДОВАТЕЛСКАТА ФАРМАЦЕВТИЧНА ИНДУСТРИЯ В БЪЛГАРИЯ СЪГЛАСНО РАЗПОРЕДБИТЕ НА ЧЛЕН 9 ОТ КОДЕКСА. От Етичния кодекс на ARPharM. И да се съобразят приложимите правила и разпоредби, когато вземат решение дали да спонсорират, участват или сътрудничат в дадено събитие. От Етичния кодекс на Асоциацията.
Regulations, safety and supply. HTA and Relative Efficacy Assessment. Disclosure of payments to HCPs. Regulations, safety and supply. HTA and Relative Efficacy Assessment. Illness never sleeps, so neither do we. IP rights and EU pharmaceutical incentives enable innovation for the cures of tomorrow.
Καλές πρακτικές στην Φαρμακευτική Ιατρική. Περιορισμοί διεξαγωγής συνεδρίων επιστημονικών εκδηλώσεων. Κωδικοποίηση και Σειριοποίηση Φαρμάκων 24-11-2016. Εκδήλωση Μητρώα Ασθενών - Δεοντολογικό Πλαίσιο 29-10-2015. Απολογισμός ΔΣ - Νέος Κανονισμός για Κλινικές Μελέτες και ετοιμότητα εφαρμογής στην Ελλάδα 11-6-2015. 1ο Συνέδριο ΕΛΕΦΙ - Υλικό.
Is a platform, supported by MedTech Europe. Dedicated to ethics and compliance projects in the MedTech industry. A unique initiative that assesses the conformity of third-party educational events with the MedTech Europe Code. A European centralised platform for MedTech companies to disclose publicly the financial support they provide to independent medical education. Status means the Event is eligible to receive financial support from MedTech Europe members.
The pharmaceutical industry recognises that it has a responsibility to show leadership in advancing responsible transparency. The industry supports measures that will enhance relationships between industry, healthcare practitioners, patients and citizens at large and advance public health. The Disclosure Code has been approved by the General Assembly on 24 June 2013. The final edited versions of the Code has been submitted to Compliance Committee comments, and has been reviewed by legal counsel.
Profesionales Sanitarios y Organizaciones Sanitarias. Colaboraciones con Profesionales Sanitarios y Organizaciones Sanitarias. Colaboraciones con Organizaciones de Pacientes. Healthcare Professionals and Healthcare Organisations.
WHAT DOES EFPIA-E4ETHICS.EU LOOK LIKE?
EFPIA-E4ETHICS.EU HOST
BROWSER ICON
PAGE TITLE
Events communicationDESCRIPTION
Educational Events and Ethical Evaluation. A new Observations Index. Click here to see its previous version. PRE-ASSESSMENT OF EVENTS WITH REGARD TO THE EFPIA HEALTHCARE PROFESSIONALS HCP CODE ARTICLE 10 CODE PROVISIONS. Are conscious of the importance of providing accurate, fair and objective information about medicinal products so that rational decisions can be made as to their use. The EFPIA Code on the Promotion of prescription-only medicines to, and interactions with, Healthcare Professionals.CONTENT
This domain had the following in the homepage, "Click here to see its previous version." We observed that the web page stated " PRE-ASSESSMENT OF EVENTS WITH REGARD TO THE EFPIA HEALTHCARE PROFESSIONALS HCP CODE ARTICLE 10 CODE PROVISIONS." It also stated " Are conscious of the importance of providing accurate, fair and objective information about medicinal products so that rational decisions can be made as to their use. The EFPIA Code on the Promotion of prescription-only medicines to, and interactions with, Healthcare Professionals."SEEK OTHER WEB PAGES
Peluang Usaha Terbaru di Bidang Makanan. Beberapa Peluang Usaha Menarik Makanan. Sunday, 7 September 2014. Usaha es krim layak dicoba bagi Anda yang sedang galau mencari peluang usaha baru. Anda bisa memulai usaha ini dengan hanya bermodal mesin pembuat es krim yang bisa dibeli di Toko Mesin Maksindo. Peluang Usaha Keripik Buah Sangat Menjanjikan. Peluang Usaha Keripik Buah Sangat Menjanjikan.
Regulations, safety and supply. HTA and Relative Efficacy Assessment. Disclosure of payments to HCPs. Regulations, safety and supply. HTA and Relative Efficacy Assessment. Illness never sleeps, so neither do we. IP rights and EU pharmaceutical incentives enable innovation for the cures of tomorrow.